Ishita Barua
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ishita Barua has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Michael Bretthauer
Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway
6 shared publications- Yuichi Mori
Department of Transplantation Medicine, Gastroenterology Section, Oslo University Hospital, Oslo, Norway
6 shared publications - Bu'HUssain Hayee
Department of Gastroenterology, King’s College London, London, UK
5 shared publications Magnus Løberg
Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway
5 shared publications- Masashi Misawa
Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan
5 shared publications Mette Kalager
Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway
5 shared publications
Latest Publications
- Open Access
- 7 October 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (03) , 303-309
Environmental impact of computer-aided diagnosis in colonoscopy: a carbon footprint assessment of a prospective study cohort
The environmental impact of computer-aided diagnosis (CADx) in colonoscopy is unknown. The potential to reduce greenhouse gas emissions by limiting unnecessary polypectomies may be offset by emissions associated with CADx devices. We quantified and compared the carbon footprint of colonoscopy with and without CADx. Life-cycle carbon emissions associated with endoscopic snares, polyp traps, histopathology, and CADx devices were estimated using life-cycle assessment software. The effect of CADx was estimated by the carbon dioxide equivalent (CO2e) emissions related to outcomes from a prospective cohort of patients who underwent colonoscopy with optical diagnosis under a leave-in-situ strategy (i.e. rectosigmoid polyps ≤5 mm predicted as non-neoplastic were not removed) with and without CADx assistance. We analyzed 1134 individuals (median age 67 years, 59% male) with 1716 colorectal polyps. Colonoscopy with CADx reduced the number of snares and polyp traps from 567 to 543 (difference: 24) and histopathology submissions from 1343 to 1278 (difference: 65). However, the total carbon footprint increased from 832 kg CO2e (95%CI 815 to 847) without CADx to 946 kg CO2e (95%CI 927 to 965) with CADx, corresponding to an absolute increase of 114 kg CO2e (95%CI 80 to 150) or 0.10 kg CO2e per colonoscopy. Using CADx under a leave-in-situ strategy increased the environmental burden of colonoscopy.
- 7 October 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (03) , 303-309
Open AccessEnvironmental impact of computer-aided diagnosis in colonoscopy: a carbon footprint assessment of a prospective study cohort
The environmental impact of computer-aided diagnosis (CADx) in colonoscopy is unknown. The potential to reduce greenhouse gas emissions by limiting unnecessary polypectomies may be offset by emissions associated with CADx devices. We quantified and compared the carbon footprint of colonoscopy with and without CADx. Life-cycle carbon emissions associated with endoscopic snares, polyp traps, histopathology, and CADx devices were estimated using life-cycle assessment software. The effect of CADx was estimated by the carbon dioxide equivalent (CO2e) emissions related to outcomes from a prospective cohort of patients who underwent colonoscopy with optical diagnosis under a leave-in-situ strategy (i.e. rectosigmoid polyps ≤5 mm predicted as non-neoplastic were not removed) with and without CADx assistance. We analyzed 1134 individuals (median age 67 years, 59% male) with 1716 colorectal polyps. Colonoscopy with CADx reduced the number of snares and polyp traps from 567 to 543 (difference: 24) and histopathology submissions from 1343 to 1278 (difference: 65). However, the total carbon footprint increased from 832 kg CO2e (95%CI 815 to 847) without CADx to 946 kg CO2e (95%CI 927 to 965) with CADx, corresponding to an absolute increase of 114 kg CO2e (95%CI 80 to 150) or 0.10 kg CO2e per colonoscopy. Using CADx under a leave-in-situ strategy increased the environmental burden of colonoscopy.
- 28 February 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (06) , C6
Correction: Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study
‡ Joint first authors * Joint last authors Article published online: 28 February 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 28 February 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (06) , C6
Correction: Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study
‡ Joint first authors * Joint last authors Article published online: 28 February 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 25 February 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (06) , 611-619
Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study
Background Computer-aided diagnosis (CADx) enables the distinction between neoplastic and non-neoplastic polyps during colonoscopy. We aimed to estimate the patient-level benefit and harm of CADx. Methods We conducted a comparative analysis on data from the EndoBRAIN international clinical trial, evaluating the effect of optical diagnosis during colonoscopy with and without CADx. Three hypothetical scenarios were compared: “endoscopist-alone” and “CADx-assisted” leave-in-situ strategies (leaving non-neoplastic rectosigmoid polyps ≤ 5 mm), and “total removal” (removing all detected polyps). Primary outcomes included patient-level colonoscopy-related cost and surveillance interval agreement (colorectal cancer risk category). Estimates were calculated based on national reimbursement rates and guidelines in four countries. Results We analyzed 1134 patients (59 % men, median age 67 years) with 1716 polyps. Compared with total removal, the endoscopist-alone and CADx-assisted leave-in-situ strategies reduced the removed polyps per patient from 1.51 (95 %CI 1.48–1.54) to 1.18 (95 %CI 1.16–1.20) and 1.12 (95 %CI 1.00–1.14), respectively; however, 0.023 (95 %CI 0.015–0.033) and 0.021 (95 %CI 0.014–0.031) neoplasms per patient were left in situ, respectively. The mean colonoscopy cost decreased by $44 (endoscopist alone) and $46 (CADx assistance) in the USA, $22 and $19 in the UK, $21 and $19 in Japan, and $32 and $30 in Norway, respectively. Surveillance interval agreement decreased to 99.2 % (endoscopist alone) and 99.0 % (CADx assistance) in the USA, 99.8 % and 99.8 % in the UK, 97.9 % and 97.1 % in Japan, and 99.9 % and 99.9 % in Norway, respectively. Conclusions Both endoscopist-alone and CADx-assisted optical diagnosis reduce colonoscopy costs. The risk of missed adenomas and surveillance interval deviations appear marginal. ‡ Joint first authors * Joint last authors Received: 19 August 2024 Accepted after revision: 08 January 2025 Article published online: 25 February 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 25 February 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (06) , 611-619
Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study
Background Computer-aided diagnosis (CADx) enables the distinction between neoplastic and non-neoplastic polyps during colonoscopy. We aimed to estimate the patient-level benefit and harm of CADx. Methods We conducted a comparative analysis on data from the EndoBRAIN international clinical trial, evaluating the effect of optical diagnosis during colonoscopy with and without CADx. Three hypothetical scenarios were compared: “endoscopist-alone” and “CADx-assisted” leave-in-situ strategies (leaving non-neoplastic rectosigmoid polyps ≤ 5 mm), and “total removal” (removing all detected polyps). Primary outcomes included patient-level colonoscopy-related cost and surveillance interval agreement (colorectal cancer risk category). Estimates were calculated based on national reimbursement rates and guidelines in four countries. Results We analyzed 1134 patients (59 % men, median age 67 years) with 1716 polyps. Compared with total removal, the endoscopist-alone and CADx-assisted leave-in-situ strategies reduced the removed polyps per patient from 1.51 (95 %CI 1.48–1.54) to 1.18 (95 %CI 1.16–1.20) and 1.12 (95 %CI 1.00–1.14), respectively; however, 0.023 (95 %CI 0.015–0.033) and 0.021 (95 %CI 0.014–0.031) neoplasms per patient were left in situ, respectively. The mean colonoscopy cost decreased by $44 (endoscopist alone) and $46 (CADx assistance) in the USA, $22 and $19 in the UK, $21 and $19 in Japan, and $32 and $30 in Norway, respectively. Surveillance interval agreement decreased to 99.2 % (endoscopist alone) and 99.0 % (CADx assistance) in the USA, 99.8 % and 99.8 % in the UK, 97.9 % and 97.1 % in Japan, and 99.9 % and 99.9 % in Norway, respectively. Conclusions Both endoscopist-alone and CADx-assisted optical diagnosis reduce colonoscopy costs. The risk of missed adenomas and surveillance interval deviations appear marginal. ‡ Joint first authors * Joint last authors Received: 19 August 2024 Accepted after revision: 08 January 2025 Article published online: 25 February 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 15 December 2022
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (6) , 664-670
Speedometer for withdrawal time monitoring during colonoscopy: a clinical implementation trial
Meticulous inspection of the mucosa during colonoscopy, represents a lengthier withdrawal time, but has been shown to increase adenoma detection rate (ADR). We investigated if artificial intelligen...
- 15 December 2022
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (6) , 664-670
Open AccessSpeedometer for withdrawal time monitoring during colonoscopy: a clinical implementation trial
Meticulous inspection of the mucosa during colonoscopy, represents a lengthier withdrawal time, but has been shown to increase adenoma detection rate (ADR). We investigated if artificial intelligen...
P282 Artificial intelligence for real-time optical diagnosis of neoplastic polyps during colonoscopy
Background Current colonoscopy practice allows endoscopists to leave tiny hyperplastic polyps in-situ in the rectosigmoid colon if endoscopic diagnosis is done with a high level of accuracy and confidence. Artificial intelligence (AI) is expected to further facilitate this process, however, there are no studies that have evaluated the additional value of using AI in polyp assessment. Methods This is a prospective, open-label, comparative, multicenter trial. We enrolled patients scheduled for screening, surveillance, diagnostic, or therapeutic colonoscopy at three hospitals in Norway, the United Kingdom and Japan. All patients with colorectal polyps ≤ 5 mm in rectosigmoid colon underwent visual inspection to assess polyp histology (adenoma vs non-adenoma). This assessment was done firstly by endoscopists alone followed by an inspection with the aid of the AI device for polyp classification. The primary endpoint was an increased sensitivity to differentiate adenomas with the use of AI. We also evaluated the specificity to differentiate adenomas and confidence level of endoscopists’ prediction as secondary outcome measures. McNemar’s test was used for the analyses. Results Out of the 1,289 recruited participants, we enrolled 531 participants (64% men with average age 67 years, 36% women with average age 65 years) who had colorectal polyps ≤ 5 mm in rectosigmoid colon. A total of 894 eligible polyps (359 adenomas and 535 non-adenomas) of these patients were assessed through visual inspection. There is no significant difference in the sensitivity to differentiate adenomas between endoscopists’ inspection alone and inspection with the aid of AI (88.9% [95% confidence interval, 85.1-91.9] versus 90.5% [87.0-93.4]; Absolute difference 1.7% (95%CI: -1.4-4.7), P=0.33). The specificity to identify adenomas increased with the use of AI (83.6% [80.1-86.6] versus 86.4% [83.2-89.1]; absolute difference 2.8% [95% CI, 0.2-5.4], P=0.03). The confidence level of endoscopists’ prediction also increased from 65.7% to 86.9%. Conclusions Use of AI for polyp classification did not improve the sensitivity to differentiate adenomas in the rectosigmoid colon. However, higher specificity and confidence level in polyp classification under the use of AI may contribute to broader use of optical assessment of polyps and reduction of unnecessary polyp removal and the associated costs.
P282 Artificial intelligence for real-time optical diagnosis of neoplastic polyps during colonoscopy
Background Current colonoscopy practice allows endoscopists to leave tiny hyperplastic polyps in-situ in the rectosigmoid colon if endoscopic diagnosis is done with a high level of accuracy and confidence. Artificial intelligence (AI) is expected to further facilitate this process, however, there are no studies that have evaluated the additional value of using AI in polyp assessment. Methods This is a prospective, open-label, comparative, multicenter trial. We enrolled patients scheduled for screening, surveillance, diagnostic, or therapeutic colonoscopy at three hospitals in Norway, the United Kingdom and Japan. All patients with colorectal polyps ≤ 5 mm in rectosigmoid colon underwent visual inspection to assess polyp histology (adenoma vs non-adenoma). This assessment was done firstly by endoscopists alone followed by an inspection with the aid of the AI device for polyp classification. The primary endpoint was an increased sensitivity to differentiate adenomas with the use of AI. We also evaluated the specificity to differentiate adenomas and confidence level of endoscopists’ prediction as secondary outcome measures. McNemar’s test was used for the analyses. Results Out of the 1,289 recruited participants, we enrolled 531 participants (64% men with average age 67 years, 36% women with average age 65 years) who had colorectal polyps ≤ 5 mm in rectosigmoid colon. A total of 894 eligible polyps (359 adenomas and 535 non-adenomas) of these patients were assessed through visual inspection. There is no significant difference in the sensitivity to differentiate adenomas between endoscopists’ inspection alone and inspection with the aid of AI (88.9% [95% confidence interval, 85.1-91.9] versus 90.5% [87.0-93.4]; Absolute difference 1.7% (95%CI: -1.4-4.7), P=0.33). The specificity to identify adenomas increased with the use of AI (83.6% [80.1-86.6] versus 86.4% [83.2-89.1]; absolute difference 2.8% [95% CI, 0.2-5.4], P=0.03). The confidence level of endoscopists’ prediction also increased from 65.7% to 86.9%. Conclusions Use of AI for polyp classification did not improve the sensitivity to differentiate adenomas in the rectosigmoid colon. However, higher specificity and confidence level in polyp classification under the use of AI may contribute to broader use of optical assessment of polyps and reduction of unnecessary polyp removal and the associated costs.
- 14 April 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (S 01) , S5-S6
ARTIFICIAL INTELLIGENCE FOR REAL-TIME OPTICAL DIAGNOSIS OF NEOPLASTIC POLYPS DURING COLONOSCOPY
Aims Artificial intelligence using computer-aided diagnosis (CADx) may enable colonoscopists to distinguish between neoplastic polyps requiring removal and non-neoplastic polyps not requiring removal during colonoscopy. This may reduce costs and resources and prevent polyp overtreatment in colorectal cancer screening. Methods We performed a multicenter clinical trial comparing a novel CADx system using real-time ultra-magnifying polyp visualization during colonoscopy with standard visual inspection of small (≤5mm in diameter) polyps in the sigmoid colon and the rectum for optical diagnosis of neoplastic histology. All polyps were subsequently removed. The primary endpoint was sensitivity for neoplastic polyps compared to histopathology. Secondary endpoints were specificity and colonoscopist confidence level of optical diagnosis. Results We assessed 1,289 individuals for eligibility at colonoscopy centers in Norway, the United Kingdom and Japan. We detected 892 eligible polyps in 518 patients and included them in analyses; 359 neoplastic and 533 non-neoplastic. Sensitivity for diagnosis of neoplastic polyps with standard visual inspection was 88.4% (95% confidence interval (CI) 84.3-91.5) compared to 90.4% (95%CI 86.8-93.1) with CADx (p=0.33). Specificity was 83.1% (95%CI 79.2-86.4) with standard visual inspection and 85.9% (95%CI 82.3-88.8) with CADx (p=0.04). The proportion of polyp assessment with high confidence was 74.2% (95%CI 70.9-77.3) with standard visual inspection versus 92.6% (95%CI 90.6-94.3) with CADx (p<0.001). Conclusions Real-time polyp assessment with CADx did not significantly increase sensitivity for neoplastic polyps, but increased specificity and improved confidence of optical diagnosis. (UMIN no. 000035213; funding Norwegian Research Council, Norwegian Cancer Society, Japan Society for the Promotion of Science) Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (S 01) , S5-S6
ARTIFICIAL INTELLIGENCE FOR REAL-TIME OPTICAL DIAGNOSIS OF NEOPLASTIC POLYPS DURING COLONOSCOPY
Aims Artificial intelligence using computer-aided diagnosis (CADx) may enable colonoscopists to distinguish between neoplastic polyps requiring removal and non-neoplastic polyps not requiring removal during colonoscopy. This may reduce costs and resources and prevent polyp overtreatment in colorectal cancer screening. Methods We performed a multicenter clinical trial comparing a novel CADx system using real-time ultra-magnifying polyp visualization during colonoscopy with standard visual inspection of small (≤5mm in diameter) polyps in the sigmoid colon and the rectum for optical diagnosis of neoplastic histology. All polyps were subsequently removed. The primary endpoint was sensitivity for neoplastic polyps compared to histopathology. Secondary endpoints were specificity and colonoscopist confidence level of optical diagnosis. Results We assessed 1,289 individuals for eligibility at colonoscopy centers in Norway, the United Kingdom and Japan. We detected 892 eligible polyps in 518 patients and included them in analyses; 359 neoplastic and 533 non-neoplastic. Sensitivity for diagnosis of neoplastic polyps with standard visual inspection was 88.4% (95% confidence interval (CI) 84.3-91.5) compared to 90.4% (95%CI 86.8-93.1) with CADx (p=0.33). Specificity was 83.1% (95%CI 79.2-86.4) with standard visual inspection and 85.9% (95%CI 82.3-88.8) with CADx (p=0.04). The proportion of polyp assessment with high confidence was 74.2% (95%CI 70.9-77.3) with standard visual inspection versus 92.6% (95%CI 90.6-94.3) with CADx (p<0.001). Conclusions Real-time polyp assessment with CADx did not significantly increase sensitivity for neoplastic polyps, but increased specificity and improved confidence of optical diagnosis. (UMIN no. 000035213; funding Norwegian Research Council, Norwegian Cancer Society, Japan Society for the Promotion of Science) Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 1 January 2022
- Published by OAE Publishing Inc. in Mini-invasive Surgery
- Vol. 6 (5) , 28
Computer-aided quality assessment (CAQ): the next step for artificial intelligence in colonoscopy?
Mini-invasive Surgery is an open access journal, focusing on endoscopy and other minimally invasive procedures research.
- 1 January 2022
- Published by OAE Publishing Inc. in Mini-invasive Surgery
- Vol. 6 (5) , 28
Open AccessComputer-aided quality assessment (CAQ): the next step for artificial intelligence in colonoscopy?
Mini-invasive Surgery is an open access journal, focusing on endoscopy and other minimally invasive procedures research.
- Open Access
- 30 October 2021
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 55 (4) , 412-421
Long‐term colorectal cancer incidence and mortality after adenoma removal in women and men
Summary: Background: Women and men with colorectal adenomas are at increased risk of colorectal cancer and colonoscopic surveillance is recommended. However, the long‐term cancer risk remains unknown.Aims: To investigate colorectal cancer incidence and mortality after adenoma removal in women and menMethods: We identified all individuals who had adenomas removed in Norway from 1993 to 2007, with follow‐up through 2018. We calculated standardized incidence ratios (SIR) and incidence‐based mortality ratios (SMR) with 95% confidence intervals (CI) for colorectal cancer in women and men using the female and male population for comparison. We defined high‐risk adenomas as ≥2 adenomas, villous component, or high‐grade dysplasia.Results: The cohort comprised 40 293 individuals. During median follow‐up of 13.0 years, 1079 women (5.5%) and 866 men (4.2%) developed colorectal cancer; 328 women (1.7%) and 275 men (1.3%) died of colorectal cancer. Colorectal cancer incidence was more increased in women (SIR 1.64, 95% CI 1.54‐1.74) than in men (SIR 1.12, 95% CI 1.05‐1.19). Colorectal cancer mortality was increased in women (SMR 1.13, 95% CI 1.02‐1.26) and reduced in men (SMR 0.79, 95% CI 0.71‐0.89). Women with high‐risk adenomas had an increased risk of colorectal cancer death (SMR 1.37, 95% CI 1.19‐1.57); women with low‐risk adenomas (SMR 0.90, 95% CI 0.76‐1.07) and men with high‐risk adenomas had a similar risk (SMR 0.89, 95% CI 0.76‐1.04), while men with low‐risk adenomas had reduced risk (SMR 0.70, 95% CI 0.59‐0.84).Conclusions: After adenoma removal, women had an increased risk of colorectal cancer death, while men had reduced risk, compared to the general female and male populations. Sex‐specific surveillance recommendations after adenoma removal should be considered.
- 30 October 2021
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 55 (4) , 412-421
Open AccessLong‐term colorectal cancer incidence and mortality after adenoma removal in women and men
Summary: Background: Women and men with colorectal adenomas are at increased risk of colorectal cancer and colonoscopic surveillance is recommended. However, the long‐term cancer risk remains unknown.Aims: To investigate colorectal cancer incidence and mortality after adenoma removal in women and menMethods: We identified all individuals who had adenomas removed in Norway from 1993 to 2007, with follow‐up through 2018. We calculated standardized incidence ratios (SIR) and incidence‐based mortality ratios (SMR) with 95% confidence intervals (CI) for colorectal cancer in women and men using the female and male population for comparison. We defined high‐risk adenomas as ≥2 adenomas, villous component, or high‐grade dysplasia.Results: The cohort comprised 40 293 individuals. During median follow‐up of 13.0 years, 1079 women (5.5%) and 866 men (4.2%) developed colorectal cancer; 328 women (1.7%) and 275 men (1.3%) died of colorectal cancer. Colorectal cancer incidence was more increased in women (SIR 1.64, 95% CI 1.54‐1.74) than in men (SIR 1.12, 95% CI 1.05‐1.19). Colorectal cancer mortality was increased in women (SMR 1.13, 95% CI 1.02‐1.26) and reduced in men (SMR 0.79, 95% CI 0.71‐0.89). Women with high‐risk adenomas had an increased risk of colorectal cancer death (SMR 1.37, 95% CI 1.19‐1.57); women with low‐risk adenomas (SMR 0.90, 95% CI 0.76‐1.07) and men with high‐risk adenomas had a similar risk (SMR 0.89, 95% CI 0.76‐1.04), while men with low‐risk adenomas had reduced risk (SMR 0.70, 95% CI 0.59‐0.84).Conclusions: After adenoma removal, women had an increased risk of colorectal cancer death, while men had reduced risk, compared to the general female and male populations. Sex‐specific surveillance recommendations after adenoma removal should be considered.
- Open Access
Mortality in Norway and Sweden before and after the Covid-19 outbreak: a cohort study
Objectives: Norway and Sweden are similar countries regarding ethnicity, socioeconomics and health care. To combat Covid-19, Norway implemented extensive measures such as school closures and lock-downs, while Sweden has been criticised for relaxed measures against Covid-19. We compared the effect of the different national strategies on all-cause and Covid-19 associated mortality. Design: Retrospective cohort. Setting: The countries Norway and Sweden. Participants: All inhabitants. Main outcome measures: We calculated weekly mortality rates (MR) with 95% confidence intervals (CI) per 100,000 individuals as well as mortality rate ratios (MRR) comparing the epidemic year (29 th July, 2019 to 26 th July, 2020) to the four preceding years (July 2015 to July 2019). We also compared Covid-19 associated deaths and mortality rates for the weeks of the epidemic in Norway and Sweden (16 th March to 26 th July, 2020). Results: In Norway, mortality rates were stable during the first three 12-month periods of 2015/16; 2016/17 and 2017/18 (MR 14.8 to 15.1 per 100,000), and slightly lower in the two most recent periods including during epidemic period (2018/19 and 2019/20; 14.5 per 100,000). In Sweden, all-cause mortality was stable during the first three 12-month periods of 2015/16; 2016/17 and 2017/18 (MR 17.2 to 17.5 per 100,000), but lower in the year 2018/19 immediately preceding the epidemic (16.2 per 100,000). Covid-19 associated mortality rates were 0.2 per 100,000 (95%CI 0.1 to 0.4) in Norway and 2.9 (95%CI 1.9 to 3.9) in Sweden. The increase in mortality was confined to individuals in 70 years or older. Conclusions: All-cause mortality remained unaltered in Norway. In Sweden, the observed increase in all-cause mortality during Covid-19 was partly due to a lower than expected mortality preceding the epidemic and the observed excess mortality, was followed by a lower than expected mortality after the first Covid-19 wave. This may suggest mortality displacement. Strengths and limitations of this study: Compares two similar contries in all aspects but the handling of the Covid-19 epidemic Evaluates the mortality for several years before and during the epidemic Provides a possible explanation of the observed mortality changes Discusses the socioeconomic effects of the different strategies in the two countries Does not evaluate cause-specific mortality
Open AccessMortality in Norway and Sweden before and after the Covid-19 outbreak: a cohort study
Objectives: Norway and Sweden are similar countries regarding ethnicity, socioeconomics and health care. To combat Covid-19, Norway implemented extensive measures such as school closures and lock-downs, while Sweden has been criticised for relaxed measures against Covid-19. We compared the effect of the different national strategies on all-cause and Covid-19 associated mortality. Design: Retrospective cohort. Setting: The countries Norway and Sweden. Participants: All inhabitants. Main outcome measures: We calculated weekly mortality rates (MR) with 95% confidence intervals (CI) per 100,000 individuals as well as mortality rate ratios (MRR) comparing the epidemic year (29 th July, 2019 to 26 th July, 2020) to the four preceding years (July 2015 to July 2019). We also compared Covid-19 associated deaths and mortality rates for the weeks of the epidemic in Norway and Sweden (16 th March to 26 th July, 2020). Results: In Norway, mortality rates were stable during the first three 12-month periods of 2015/16; 2016/17 and 2017/18 (MR 14.8 to 15.1 per 100,000), and slightly lower in the two most recent periods including during epidemic period (2018/19 and 2019/20; 14.5 per 100,000). In Sweden, all-cause mortality was stable during the first three 12-month periods of 2015/16; 2016/17 and 2017/18 (MR 17.2 to 17.5 per 100,000), but lower in the year 2018/19 immediately preceding the epidemic (16.2 per 100,000). Covid-19 associated mortality rates were 0.2 per 100,000 (95%CI 0.1 to 0.4) in Norway and 2.9 (95%CI 1.9 to 3.9) in Sweden. The increase in mortality was confined to individuals in 70 years or older. Conclusions: All-cause mortality remained unaltered in Norway. In Sweden, the observed increase in all-cause mortality during Covid-19 was partly due to a lower than expected mortality preceding the epidemic and the observed excess mortality, was followed by a lower than expected mortality after the first Covid-19 wave. This may suggest mortality displacement. Strengths and limitations of this study: Compares two similar contries in all aspects but the handling of the Covid-19 epidemic Evaluates the mortality for several years before and during the epidemic Provides a possible explanation of the observed mortality changes Discusses the socioeconomic effects of the different strategies in the two countries Does not evaluate cause-specific mortality
- Top Cited Papers
- 17 June 2020
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 53 (03) , 277-284
Artificial intelligence for polyp detection during colonoscopy: a systematic review and meta-analysis
Background Artificial intelligence (AI)-based polyp detection systems are used during colonoscopy with the aim of increasing lesion detection and improving colonoscopy quality. Patients and methods: We performed a systematic review and meta-analysis of prospective trials to determine the value of AI-based polyp detection systems for detection of polyps and colorectal cancer. We performed systematic searches in MEDLINE, EMBASE, and Cochrane CENTRAL. Independent reviewers screened studies and assessed eligibility, certainty of evidence, and risk of bias. We compared colonoscopy with and without AI by calculating relative and absolute risks and mean differences for detection of polyps, adenomas, and colorectal cancer. Results Five randomized trials were eligible for analysis. Colonoscopy with AI increased adenoma detection rates (ADRs) and polyp detection rates (PDRs) compared to colonoscopy without AI (values given with 95 %CI). ADR with AI was 29.6 % (22.2 % – 37.0 %) versus 19.3 % (12.7 % – 25.9 %) without AI; relative risk (RR] 1.52 (1.31 – 1.77), with high certainty. PDR was 45.4 % (41.1 % – 49.8 %) with AI versus 30.6 % (26.5 % – 34.6 %) without AI; RR 1.48 (1.37 – 1.60), with high certainty. There was no difference in detection of advanced adenomas (mean advanced adenomas per colonoscopy 0.03 for each group, high certainty). Mean adenomas detected per colonoscopy was higher for small adenomas (≤ 5 mm) for AI versus non-AI (mean difference 0.15 [0.12 – 0.18]), but not for larger adenomas (> 5 – ≤ 10 mm, mean difference 0.03 [0.01 – 0.05]; > 10 mm, mean difference 0.01 [0.00 – 0.02]; high certainty). Data on cancer are unavailable. Conclusions AI-based polyp detection systems during colonoscopy increase detection of small nonadvanced adenomas and polyps, but not of advanced adenomas.
- 17 June 2020
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 53 (03) , 277-284
Top Cited PapersArtificial intelligence for polyp detection during colonoscopy: a systematic review and meta-analysis
Background Artificial intelligence (AI)-based polyp detection systems are used during colonoscopy with the aim of increasing lesion detection and improving colonoscopy quality. Patients and methods: We performed a systematic review and meta-analysis of prospective trials to determine the value of AI-based polyp detection systems for detection of polyps and colorectal cancer. We performed systematic searches in MEDLINE, EMBASE, and Cochrane CENTRAL. Independent reviewers screened studies and assessed eligibility, certainty of evidence, and risk of bias. We compared colonoscopy with and without AI by calculating relative and absolute risks and mean differences for detection of polyps, adenomas, and colorectal cancer. Results Five randomized trials were eligible for analysis. Colonoscopy with AI increased adenoma detection rates (ADRs) and polyp detection rates (PDRs) compared to colonoscopy without AI (values given with 95 %CI). ADR with AI was 29.6 % (22.2 % – 37.0 %) versus 19.3 % (12.7 % – 25.9 %) without AI; relative risk (RR] 1.52 (1.31 – 1.77), with high certainty. PDR was 45.4 % (41.1 % – 49.8 %) with AI versus 30.6 % (26.5 % – 34.6 %) without AI; RR 1.48 (1.37 – 1.60), with high certainty. There was no difference in detection of advanced adenomas (mean advanced adenomas per colonoscopy 0.03 for each group, high certainty). Mean adenomas detected per colonoscopy was higher for small adenomas (≤ 5 mm) for AI versus non-AI (mean difference 0.15 [0.12 – 0.18]), but not for larger adenomas (> 5 – ≤ 10 mm, mean difference 0.03 [0.01 – 0.05]; > 10 mm, mean difference 0.01 [0.00 – 0.02]; high certainty). Data on cancer are unavailable. Conclusions AI-based polyp detection systems during colonoscopy increase detection of small nonadvanced adenomas and polyps, but not of advanced adenomas.